AbbVie Inc 2022 SR
The report highlights AbbVie's 2022 ESG progress, marking its tenth year as an independent company. Key achievements include a 15.6% reduction in Scope 1 and 2 greenhouse gas emissions and a 20% reduction in waste generation, meeting its 2025 target early. The company invested $7.1 billion in adjusted R&D and provided medicine at no cost to over 198,000 U.S. patients through assistance programs. Additionally, AbbVie committed to new science-based targets validated by the SBTi and achieved a 40% representation of women in vice president and above positions.
Company: AbbVie Inc
Sector: Information Information Technology
Country: United States
Year: 2022
Type: SR
Pages: 45
AbbVie Inc
ESG Action Report
The report highlights AbbVie's 2022 ESG progress, marking its tenth year as an independent company. Key achievements include a 15.6% reduction in Scope 1 and 2 greenhouse gas emissions and a 20% reduction in waste generation, meeting its 2025 target early. The company invested $7.1 billion in adjusted R&D and provided medicine at no cost to over 198,000 U.S. patients through assistance programs. Additionally, AbbVie committed to new science-based targets validated by the SBTi and achieved a 40% representation of women in vice president and above positions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees